IL17A and glioblastoma: Immunohistochemistry (IHC) staining assay was performed to examine the IL‐17A expression in paraffin‐embedded tissues from 57 GBM patients (WHO I+II: 13, WHO III: 17, WHO IV: 27) and six adjacent benign control tissues.